To further extend these findings in other cancer cells, we generated stable knockdowns of OMA1 in patient-derived breast cancer cells isolated from atypical ductal hyperplasia (21PT) using OMA1-specific shRNAs. The gene discussed is OMA1; the disease is cancer.